Aurora Cannabis Inc. (TSE:ACB) shares have had a really impressive month, gaining 27% after a shaky period beforehand. The bad news is that even after the stocks recovery in the last 30 days, shareholders are still underwater by about 4.6% over the last year.
In spite of the firm bounce in price, you could still be forgiven for feeling indifferent about Aurora Cannabis’ P/S ratio of 1.2x, since the median price-to-sales (or “P/S”) ratio for the Pharmaceuticals industry in Canada is also close to 1.1x. However, investors might be overlooking a clear opportunity or potential setback if there is no rational basis for the P/S.
Check out our latest analysis for Aurora Cannabis
What Does Aurora Cannabis’ Recent Performance Look Like?
With revenue…
